Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems.
- 5 February 1983
- Vol. 286 (6363), 458-460
- https://doi.org/10.1136/bmj.286.6363.458
Abstract
The process of discovery for 18 important adverse drug reactions was analysed in terms of study designs and other features which determined whether published reports of suspected adverse reactions were convincing or provided valid evidence of causality. First alerts were almost always anecdotal reports. For earlier alerting during clinical trials event recording is needed, associated with dose-response data and the use of patients as their own controls.This publication has 5 references indexed in Scilit:
- Identification of adverse reactions to new drugs. II (continued): How were 18 important adverse reactions discovered and with what delays?BMJ, 1983
- Identification of adverse reactions to new drugs. II--How were 18 important adverse reactions discovered and with what delays?BMJ, 1983
- Identification of adverse reactions to new drugs. I: What have been the important adverse reactions since thalidomide?BMJ, 1983
- Validity of anecdotal reports of suspected adverse drug reactions: the problem of false alarmsBMJ, 1982
- Record linkage for drug monitoring.Journal of Epidemiology and Community Health, 1981